Revealing Molecular Switches for Heart Disease
Revealing Molecular Switches for Heart Disease
Michael Alexanian joins Gladstone Institutes to discover new targets for treating and reversing heart failure
Institutional News News Release Profile Heart Failure Cardiovascular Disease Alexanian Lab